Science Current Events | Science News | Brightsurf.com
 

Ohio State researchers discover hereditary predisposition of melanoma of the eye

December 16, 2011
COLUMBUS, Ohio - Ohio State University researchers have discovered a hereditary cancer syndrome that predisposes certain people to a melanoma of the eye, along with lung cancer, brain cancer and possibly other types of cancer.

The hereditary cancer syndrome is caused by an inherited mutation in a gene called BAP1, researchers say.

The findings suggest that BAP1 mutations cause the disease in a small subset of patients with hereditary uveal melanoma and other cancers.

Uveal melanoma is a cancer of the eye involving the iris, ciliary body, or choroid, which are collectively known as the uvea. These tumors arise from the pigment cells, also known as melanocytes that reside within the uvea giving color to the eye. This is the most common type of eye tumor in adults.

The findings are reported in the Journal of Medical Genetics.

"We are describing a new cancer genetic syndrome that could affect how patients are treated," said first author Dr. Mohamed H. Abdel-Rahman, researcher at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. "If we know that a patient has this particular gene mutation, we can be more proactive with increased cancer screenings to try to detect these other potential cancers when they are beginning to grow."

Study leader Dr. Frederick H. Davidorf, professor emeritus of ophthalmology at Ohio State University, explained that BAP1 seems to play an important role in regulating cell growth and proliferation, and that loss of the gene helps lead to cancer.

"If our results are verified, it would be good to monitor these patients to detect these cancers early when they are most treatable," said Davidorf, who treats ocular oncology patients at Ohio State along with researcher and physician Dr. Colleen Cebulla.

The study involved 53 unrelated uveal melanoma patients with high risk for hereditary cancer, along with additional family members of one of the study participants. Of the 53 patients in the study, researchers identified germline variants in BAP1 in three patients.

"We still don't know exactly the full pattern of cancers these patients are predisposed to, and more studies are needed," said Abdel-Rahman, also an assistant professor of ophthalmology and division of human genetics at Ohio State University College of Medicine.

"So far, we've identified about six families with this hereditary cancer syndrome. We are working with researchers at Nationwide Children's Hospital to develop a clinical test to screen for the BAP1 gene mutation," he said. "Families with this cancer syndrome should be screened for inherited mutations that increase their risk for developing several other cancers."

Ohio State University Medical Center


Related Melanoma Current Events and Melanoma News Articles


Targeted combination therapy halts disease, extends life in advanced melanoma patients
A world-first study in today's New England Journal of Medicine heralds the efficacy of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.

Promising results shown with targeted approaches in subsets of non-small cell lung cancer
The BRAF inhibitor dabrafenib has significant anti-tumour activity in patients with advanced BRAF V600E mutant non-small cell lung cancer whose disease has progressed after chemotherapy, according to phase II data presented at the ESMO 2014 Congress in Madrid, Spain.

Crizotinib treatment effective against ROS1-positive lung cancer
Treatment with the targeted therapy drug crizotinib effectively halts the growth of lung tumors driven by rearrangements of the ROS1 gene.

Nivolumab shows signs of superior response rate compared to standard chemo in advanced melanoma
The monoclonal antibody nivolumab achieves superior response rates and a longer duration of response than standard chemotherapy in patients whose melanoma has progressed after treatment with ipilimumab, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain.

New data on combination treatments for melanoma
Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieves greater progression-free survival and response rates than vemurafenib plus placebo in BRAF-mutation positive melanoma, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain.

Studies report new findings on treatment options for mesothelioma
Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from a prospective randomized phase II trial presented at ESMO 2014 Congress in Madrid.

Skin pigment renders sun's UV radiation harmless using projectiles
Researchers at Lund University in Sweden and other institutions have worked out how the pigment of the skin manages to protect the body from the sun's dangerous UV rays.

Calming down immune cells could hold key to melanoma treatment
Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.

Exercise Boosts Tumor-fighting Ability of Chemotherapy, Penn Team Finds
Study after study has proven it true: exercise is good for you. But new research from University of Pennsylvania scientists suggests that exercise may have an added benefit for cancer patients undergoing chemotherapy.

Chromosome buffers hold key to better melanoma understanding
Buffers that guard against damage to the ends of chromosomes could hold the key to a better understanding of malignant melanoma - the deadliest form of skin cancer - according to new research from the University of Leeds.
More Melanoma Current Events and Melanoma News Articles

Beating Melanoma: A Five-Step Survival Guide (A Johns Hopkins Press Health Book)

Beating Melanoma: A Five-Step Survival Guide (A Johns Hopkins Press Health Book)
by Steven Q. Wang (Author)


Dr. Steven Q. Wang, a world-renowned skin cancer expert, provides an essential guide for people with melanoma and their families. The book’s unique, practical format approaches the disease in two phases, just as people with melanoma need to do. First comes a step-by-step guide for what Dr. Wang calls the "mad rush" phase—an intense and stressful period from diagnosis to completing initial treatment. Dr. Wang's calm guidance helps readers through this critical time, using an easy to understand plan for ensuring optimal treatment and survival outcomes. Once the mad rush phase is over, the "marathon phase" begins—life resumes its normal shape but with lingering concerns about new melanoma and metastases. Here Dr. Wang addresses common questions about prevention and prognosis. Beating...

A Melanoma Patient's Survival Guide: Lemons Really Do Make Lemonade: You Just Have to Add a Little Sugar

A Melanoma Patient's Survival Guide: Lemons Really Do Make Lemonade: You Just Have to Add a Little Sugar
by Sally Welsh (Author)


A Melanoma Patient’s Survival guide: Lemons Really Do Make Lemonade is an effort to bring awareness to the subject of melanoma. This insidious disease is being diagnosed in over 50,000 people a year in the United States alone. Melanoma will affect one in seventy-five people in California. That rate goes up each year. Melanoma can be a silent killer. This heart-warming book was written by a survivor of serious melanoma, Sally Welsh. Sally has shared her experience with thousands of people, and has prepared this book with the hope of making your journey a little easier. Her suggestions deal first of all with the questions you need to ask your doctor, before he cuts into you. You need to know about his initial scanning of you, whether he plans to use a “punch” biopsy or a “scrape”...

QuickFACTS Melanoma Skin Cancer: What You Need to Know-NOW

QuickFACTS Melanoma Skin Cancer: What You Need to Know-NOW
by American Cancer Society (Author)


This pocket-sized reference covers everything from the risk factors of melanoma skin cancer to the diagnosis procedure to living well after treatment. With greater public awareness, early detection of melanoma skin cancer is on the rise and mortality rates are declining; this medical guide emphasizes that all patients should be well-informed decision makers in planning their own treatment and is updated with the latest patient treatment guidelines. An advanced dictionary of cancer-related terms and a list of critical questions to ask health care administrators are also included.

My Journey with Melanoma

My Journey with Melanoma
by Stephanie Bowen (Author)


Imagine being told you have stage IV Metastatic Melanoma. A colossal hole opens up under your feet and swallows your spirit. You stop breathing, and then realize something bigger than a lack of oxygen may take your life. The Grim Reaper has knocked. In the fall of 2010, I received this diagnosis. I began the unimaginable journey of fighting cancer. This experience was truly the most frightening and terrifying event to live through. I felt compelled to write my story and to share it with people in order to giver others HOPE. Cancer feels hopeless and I poured out my heart as I wrote this story in about a week. I channeled my inner Lance Armstrong, and knew that sharing my story could be how I help others with a similar diagnosis My story is real. I shared about how I feel the cancer "got...

The Ribbon Is Black for a Reason : How Melanoma Changed My Life in Four Short Months

The Ribbon Is Black for a Reason : How Melanoma Changed My Life in Four Short Months
by AuthorHouse


In 1997 Jerry Galusha had a mole removed from his back left calf. The mole had changed which caused concern. It was biopsied and determined to be malignant. The mole was surgically removed and after a short recovery period it was all but forgotten. Yearly skin and lymph node checks kept his concerns about melanoma at bay until an unusual, relentless pain in the back of his head led to an MRI that unvailed the horrible truth; Jerry had stage IV metastisized malignant melanoma. His cancer had spread, undetected, all throughout his body over the course of that 13 years. Jerry's illness taught his friends and family the meaning of unconditional love. This is the story of the love, support, courage and devotion of a family and community to Jerry Galusha during the 4 months of the remainder of...

Histological Diagnosis of Nevi and Melanoma

Histological Diagnosis of Nevi and Melanoma
by Guido Massi (Author), Philip E. LeBoit (Author)


The interpretation of melanocytic tumors represents probably the most difficult task in the field of dermatopathology. The second edition of this text and atlas depicts a broad range of the most important and most challenging melanocytic lesions. Each individual case is illustrated with at least three high-quality color photographs and is commented on at length, highlighting the diagnostic clues. The goal of the authors is to assist the ordinary pathologist in making a precise workable diagnosis in their daily practice. They achieve this by providing simple criteria that will serve as a sound basis for an unequivocal diagnosis of either a benign or a malignant melanocytic neoplasm. The reader will find Histological Diagnosis of Nevi and Melanoma to be an invaluable guide to correct...

I Survived Metastacised Melanoma Cancer!: Hope For Melanoma Sufferers

I Survived Metastacised Melanoma Cancer!: Hope For Melanoma Sufferers
by Frank E. Burdett (Author)


I know the importance of the individual experience of metastacised melanoma cancer, because it is a very special journey. People are prone to forget, such as when one forgets they have a finger, until they hit it; people also forget they have a life until it is very seriously threatened. The worst sentence in this world that a doctor can pronounce is, "I am sorry, but the medical profession can do nothing further for you" This work explores how my wife, Jeannie, who was my home caregiver, and I travelled the cancer journey together. The journey was not the same for Jeannie as it was for me-it was my melanoma cancer, but I was Jeannie's husband, and therefore the stress was that much more for her, as she never knew what further stresses she had to face. This book examines the strengths of...

The Melanoma Book: A Complete Guide to Prevention and Treatment, Including theEarly DetectionSelf-Exam Body Map

The Melanoma Book: A Complete Guide to Prevention and Treatment, Including theEarly DetectionSelf-Exam Body Map
by Howard L. Kaufman (Author)


From the founder and Co-Director of the renowned Columbia University Melanoma Center, the first comprehensive guide to help you prevent—and survive—a diagnosis of melanoma. The fastest rising form of cancer worldwide, melanoma can strike at any age. Although rates of cure are higher than they used to be, experts often disagree about the best course of treatment and patients face a bewildering array of possibilities—often with precious little time to choose. Drawing on his years as one of the nation’s foremost researchers and specialists in the field of melanoma treatment, Dr. Howard L. Kaufman shares his easy- to-follow, whole-life plan for detecting melanoma early, making informed decisions after a diagnosis, and taking an active role in treatment.

NCCN Guidelines for Patients®: Melanoma

NCCN Guidelines for Patients®: Melanoma
by National Comprehensive Cancer Network® (NCCN®) (Author)


From the medical leaders of 25 of the world’s most renowned cancer centers united under the National Comprehensive Cancer Network® (NCCN®), comes this essential guide to melanoma. Adapted from clinical treatment guidelines used by physicians and oncology professionals around the world, these NCCN Guidelines for Patients® are packed with the latest information, treatment innovations, and resources about the diagnosis and treatment of melanoma. Each patient-friendly chapter prepares patients and caregivers to talk with their doctors and make treatment decisions. Let this authoritative handbook be your guide! Part 1 – Explains the growth and spread of melanoma skin cancer Part 2 – Describes suggested tests used to confirm melanoma and plan treatment Part 3 – Explains how doctors...

100 Questions & Answers about Melanoma & Other Skin Cancers

100 Questions & Answers about Melanoma & Other Skin Cancers
by Edward F. McClay (Author), Mary-Eileen T. McClay (Author), Jodie Smith (Author)


Whether you're a newly diagnosed skin cancer patient, a survivor, or a friend of either, this book offers help. The only text to provde the doctor and a patient's view, 100 Questions & Answers About Melanoma and Other Skin Cancers gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by two skin healthcare professionals and a melanoma survivor, this book is an invaluable resource for anyone coping with the physical and emotional turmoil of this frightening disease.

© 2014 BrightSurf.com